Literature DB >> 26255560

Increased risk of functional gastrointestinal sequelae after Clostridium difficile infection among active duty United States military personnel (1998-2010).

Ramiro L Gutiérrez1, Mark S Riddle2, Chad K Porter2.   

Abstract

BACKGROUND & AIMS: Some acute enteric infections are associated with the development of functional gastrointestinal disorders, most commonly irritable bowel syndrome but also other functional and organic gastrointestinal sequelae. Clostridium difficile infection has increased in incidence and severity, however, few studies have evaluated functional disorders after this infection.
METHODS: We evaluated the epidemiology and sequelae of C difficile in the US military population by using the US Department of Defense's Armed Forces Health Surveillance Center Defense Medical Ecounter Database. We then performed a retrospective cohort study of 891 active-duty US military personnel who developed C difficile from 1998 to 2010 and 3231 matched subjects who had not been exposed to C difficile. Subjects were identified based on International Classification of Diseases, 9th revision, Clinical Modification codes for C difficile disease.
RESULTS: C difficile was associated independently with increased rate ratios (RRs) for incident irritable bowel syndrome (RR, 6.1; 95% confidence interval [CI], 2.9-12.9), gastroesophageal reflux disease (GERD) (RR, 1.9; 95% CI, 1.4-2.6), dyspepsia (RR, 3.3; 95%, 1.4-7.7), and constipation (RR, 2.2; 95% CI, 1.3-3.7). Approximately 14.1% of subjects with C difficile later were identified with one of these functional gastrointestinal disorders (FGDs), compared with 6% of controls. Community- and health care-associated C difficile were associated at similar rates with these sequelae. Patients were at increased risk for FGDs within 3 months of a C difficile episode, with one additional case of FGD developing for every 12 diagnoses of C difficile.
CONCLUSIONS: The incidence of community- and health care-associated C difficile has increased in the US military population from 1998 through 2010. As for other gastrointestinal infections, C difficile disease is associated with clinically relevant functional sequelae in this military population.
Copyright © 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  C difficile; Effects; GERD; Outcomes

Mesh:

Year:  2015        PMID: 26255560     DOI: 10.1053/j.gastro.2015.07.059

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  10 in total

1.  Clostridium difficile-related postinfectious IBS: a case of enteroglial microbiological stalking and/or the solution of a conundrum?

Authors:  Gabrio Bassotti; Lara Macchioni; Lanfranco Corazzi; Pierfrancesco Marconi; Katia Fettucciari
Journal:  Cell Mol Life Sci       Date:  2017-12-28       Impact factor: 9.261

2.  High risk of post-infectious irritable bowel syndrome in patients with Clostridium difficile infection.

Authors:  A Wadhwa; M F Al Nahhas; R A Dierkhising; R Patel; P Kashyap; D S Pardi; S Khanna; M Grover
Journal:  Aliment Pharmacol Ther       Date:  2016-07-22       Impact factor: 8.171

3.  Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome.

Authors:  Giovanni Barbara; Madhusudan Grover; Premysl Bercik; Maura Corsetti; Uday C Ghoshal; Lena Ohman; Mirjana Rajilić-Stojanović
Journal:  Gastroenterology       Date:  2018-11-28       Impact factor: 22.682

4.  A High Rate of Alternative Diagnoses in Patients Referred for Presumed Clostridium difficile Infection.

Authors:  Melissa Jackson; Sidney Olefson; Jason T Machan; Colleen R Kelly
Journal:  J Clin Gastroenterol       Date:  2016-10       Impact factor: 3.062

Review 5.  Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology.

Authors:  Alexander Khoruts; Christopher Staley; Michael J Sadowsky
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-08-25       Impact factor: 46.802

6.  Retrospective analysis of long-term gastrointestinal symptoms after Clostridium difficile infection in a nonelderly cohort.

Authors:  Tamar F Barlam; Rene Soria-Saucedo; Omid Ameli; Howard J Cabral; Warren A Kaplan; Lewis E Kazis
Journal:  PLoS One       Date:  2018-12-17       Impact factor: 3.240

7.  S100B Inhibition Attenuates Intestinal Damage and Diarrhea Severity During Clostridioides difficile Infection by Modulating Inflammatory Response.

Authors:  Deiziane V S Costa; Vivaldo Moura-Neto; David T Bolick; Richard L Guerrant; Jibraan A Fawad; Jae H Shin; Pedro H Q S Medeiros; Solanka E Ledwaba; Glynis L Kolling; Conceição S Martins; Venkat Venkataraman; Cirle A Warren; Gerly A C Brito
Journal:  Front Cell Infect Microbiol       Date:  2021-09-10       Impact factor: 5.293

8.  P2X7 receptor blockade decreases inflammation, apoptosis, and enteric neuron loss during Clostridioides difficile toxin A-induced ileitis in mice.

Authors:  Ana A Q A Santos; Deiziane V S Costa; Danielle A Foschetti; Antoniella S G Duarte; Conceição S Martins; Pedro M G Soares; Patricia Castelucci; Gerly A C Brito
Journal:  World J Gastroenterol       Date:  2022-08-14       Impact factor: 5.374

9.  Postinfection Irritable Bowel Syndrome Following Clostridioides difficile Infection: A Systematic-review and Meta-analysis.

Authors:  Srishti Saha; Kanika Sehgal; Sumitabh Singh; Madhusudan Grover; Darrell Pardi; Sahil Khanna
Journal:  J Clin Gastroenterol       Date:  2022-02-01       Impact factor: 3.174

10.  Experience and Outcomes at a Specialized Clostridium difficile Clinical Practice.

Authors:  Raseen Tariq; Renee M Weatherly; Patricia P Kammer; Darrell S Pardi; Sahil Khanna
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2017-05-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.